Text Registration
Copyright Title
Galectins and Disease Implications for Targeted Therapeutics
Status
Published
on 25 Apr 2013
Year of Creation
2012
Copyright Claimant
American Chemical Society
Registration Number
TX0007724688
on 25 Apr 2013Copyright Summary
The U.S. Copyright record (Registration Number: TX0007724688) dated 25 Apr 2013, pertains to an electronic file (eService) titled "Galectins and Disease Implications for Targeted Therapeutics" created in 2012. The copyright holder is American Chemical Society, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to American Chemical Society.
Application Details
Registration Number
TX0007724688
Registration Date
4/25/2013
Year of Creation
2012
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Book, 443 p
First Publication Nation
United States
Notes
Rights Note: American Chemical Society, 1155 Sixteenth St., N.W., Washington, DC, 20036, United States, (202) 452-4368, copyright@acs.org
Statements
Application Title Statement: Galectins and Disease Implications for Targeted Therapeutics
Author Statement: Anatole A. Klyosov Domicile: United States Citizenship: United States Authorship: editing Peter G. Traber Domicile: United States Citizenship: United States Authorship: editing
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.